bioscience


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.

bioscience

 [bi″o-si´ens]
the study of biology wherein all the applicable sciences (such as physics, chemistry, and others) are applied.

bioscience

/bio·sci·ence/ (-si´ens) the study of biology wherein all the applicable sciences (physics, chemistry, etc.) are applied.

bioscience

(bī′ō-sī′əns)
bi′o·sci′en·tif′ic (-sī′ən-tĭf′ĭk) adj.
bi′o·sci′en·tist n.

bioscience

the study of biology wherein all the applicable sciences (physics, chemistry, etc.) are applied.
References in periodicals archive ?
This state-of-the-art facility will allow us to take advantage of our enormous scientific base and world-class research institutions to attract both start-up firms and established bioscience companies to New York City.
BioScience is the flagship publication of the American Institute of Biological Sciences, a 51 year-old federation of over 50 biological societies and associations that together comprise more than 120,000 biologists worldwide.
The report also notes that strong regional life sciences clusters, present in Indianapolis and other areas of the state, are the result of "Oeffective clustering of resources including university research, a talented labor force, availability of investment capital, and strong local firms that anchor the industry result in a strong bioscience industry at the regional level.
Bioscience should further strengthen Schering-Plough's position in Europe," said Rodolfo C.
Omeris' program will focus on attracting companies to Ohio's greatest areas of technological strength in the biosciences, including cardiology, cancer, neurosciences, medical polymers, bioinformatics, and agricultural biosciences.
The BioOhio agenda also will feature speakers with insight into the availability of both bioscience jobs and qualified candidates in Ohio.
Cenix and the Cenix BioScience logo are registered trademarks of Cenix BioScience GmbH.
2 billion were invested in 94 companies across Ohio to accelerate Ohio's bioscience growth in 2005, a jump of more than $200 million since 2004.
PURE Bioscience (OTCBB:PURE) develops and markets technology-based bioscience products that provide non-toxic solutions to numerous global health challenges.
The rising number of pharmaceutical and biotechnology companies working within drug discovery and the strong emphasis on outsourcing increases MD Biosciences market potential.
In connection with the acquisition, Cellex Biosciences has joined forces with LSL Biolafitte, the French subsidiary of LSL Group, Ltd.
Bruker BioSciences Corporation (NASDAQ:BRKR) plans to release its fourth quarter and full year 2006 financial results on Thursday, February 22nd, 2007 before the market opens.